Guzmán-Marín ES, Zavala-Castro JE, Acosta-Viana KY, Rosado-Barrera ME

Idioma: Español
Referencias bibliográficas: 38
Paginas: 177-184
Archivo PDF: 150.77 Kb.

RESUMEN

El Trypanosoma cruzi (T. cruzi) es un protozoario hemoflagelado, considerado el agente causal de la enfermedad de Chagas y es transmitido a los hospederos mamíferos por medio de insectos vectores del género Triatoma. El T. cruzi presenta un pleomorfismo natural, al cual se ha atribuido a la diferencia de severidad con que se presenta la enfermedad en el hospedero humano y otros mamíferos. Considerando este aspecto han sido varios los trabajos sobre caracterización de cepas de T. cruzi, abarcando aspectos biológicos, bioquímicos y moleculares para poder establecer un método de clasificación de las diferentes cepas de dicho parásito, de manera que las cepas que pertenezcan a un mismo grupo compartan estos aspectos y así una cepa pudiera ser representativa de ese grupo, simplificando los estudios a realizar.
Esta revisión pretende dar un panorama de los diferentes métodos de caracterización de las cepas de T. cruzi, para tratar de agruparlas para su mejor estudio y control.

REFERENCIAS (EN ESTE ARTÍCULO)

1. 1987-88: nine programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). France: WHO; 1989. p. 89-98.

2. Pinto-Dias JC. Acute Chagas disease. Mem Inst Oswaldo Cruz 1984; 79 (Suppl):85-91.

3. Tropical Disease Research: progress 1975-94: highlights 1993-94: twelfth programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: WHO; 1995. p. 125-34.

4. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. World Health Assembly Resolution. Ginebre; 1980. p. 27-52.

5. Lammel EL, Muller LA, Isola LD, Gonzalez Cappa SM. Effect of vector on infectivity of T. cruzi. Acta Trópica 1985; 42:149-55.

6. Morris SA, Tanowitz H, Hatcher D, Bilezikian JP, Wittnwe M. Alterations in intracellular calcium following infection endothelial cells with Trypanosoma cruzi. Mol Biochem Parasitol 1988; 29:213-21.

7. Rangel Aldao R, Allende D, Triana F, Piras R, Enriquez D, Piras M. Possible role of AMP cyclic in the differentiation of Trypanosoma cruzi. Mol Biochem Parasitol 1987; 22:39-43.

8. Magalhaes JB, Andrade SG,, Sherlock Y. Trypanosoma cruzi strains: behavior after passage into authoctonous or foreingn species of triatomine (biological and biochemical patterns).Rev Inst Med Trop Sao Paulo 1996; 38:23-8.

9. Tay J, Salazar-Schetino PM, Ontiveros A, Jimenez J. Epidemiología de la enfermedad de Chagas en la población de Oaxaca, Mex. Bol Of Sanit Panam 1979; 87:1-17.

10. Tay J, Lara R. Velazco O, Gutiérrez M. Parasitología Médica 5a. ed. México; Méndez Cervantes; 1991. p. 112-22.

11. Brener Z. Life cycle of Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1971; 12:171-8.

12. Brener Z. and Chiari E. Variacoes morfologicas observadas em diferentes amostras de Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 1963; 5:220-4.

13. de Souza W. Cell biology of Tripanosoma cruzi. Int Rev Cytol 1984; 86:197-282.

14. Petana WB. A revision of Trypanosoma cruzi strains from British Honduras and the importance of strains characteristics in experimental chemotherapy of Chagas disease. Trans Roy Sci Trop Med Hyg 1972 ; 66:463-70.

15. Brener Z. Recent development in the field of Chagas disease. Bull WHO 1982; 60:463-73.

16. Brener Z. General review on Trypanosoma cruzi classification and taxonomy. Rev Soc Bras Med Trop 1985; 18 (suppl):1-8.

17. Andrade SG. Morphological and behavioural characterization of Trypanosoma cruzi strains. Rev Soc Bras Med Trop 1985;18 (suppl):39-46.

18. Dvorak JA.. Host parasite relationships at the cellular level in Trypanosoma cruzi infection. Scientific Publication Washington: Panamerican Health Organization; 1977. 347:1-10.

19. Melo RC, Brener Z. Tissue tropisn of diffetent Trypanosoma cruzi strains. J Parasitol 1978; 64:475-82.

20. Bice DE, Zeledón R. Comparison of infectivity of strains of Trypanosoma cruzi J Parasitol 1970; 56:663-70.

21. de Diego JA, Penin P, del ReyJ, Mayer R, Gamallo C. A comparative pathological study of three strains of Trypanosoma cruzi in an experimental model. Histol Histopath 1991; 6:199-206.

22. Higuchi ML, De Brito T, Martins M, Barbosa A, Bellotti G. Correlation Between Trypanosoma cruzi parasitism and myocardial inflamatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Pathol 1993; 2:101-6.

23. Postn M, Bailey JJ, Dvorak JA, McDaniel JP, Pottala EW. Studies of Trypanosoma cruzi clones in inbred mice. III. Histopathology and electrocardiographical responses to chronic infection. Am J Trop Med Hyg 1987; 37:541-9.

24. Postan M, McDaniel J, Dvorak J. Studies of Trypanosoma cruzi clones in inbred mice. II. Course of infection of C57BL/6 mice with single-cell isolated stocks. Am J Trop Med Hyg 1984; 33:235-8.

25. Saravia NG, Hoilguin AF, Cibulskis RE, D’Alessandro A. Divergent isozimes profiles of selvatic and domiciliary Trypanosoma cruzi in the Eastern plains, Piedmont and Highlands of Colombia. Am J Trop Med Hyg 1987; 36:59-69.

26. Widner G, Marinkelle CJ, Gulh F, Miles MA. Isozime profiles of Trypanosoma cruzi stocks from Colombia and Ecuador. Ann Trop Med Parasitol 1985; 59:253-7.

27. Miles MA, Cedillos RA, Povoa MM, Souza AA, de Prata A, Macedo V. Do radically dissimilar Trypanosoma cruzi strains (zymodemes) cause Venezuelan and Brazilian form Chagas’ disease. Lancet 1981; 1:1338-40.

28. Tibayrenc M, Miles Ma. A genetic comparison between Brazilian and Bolivian zymodemes of Trypanosoma cruzi. Trans Roy Sci Trop Med Hyg 1983; 77:76-83.

29. Bogliolo AR, Godfrey DG. Isoenzime changes during the life cycle of Trypanosoma cruzi. Trans Roy Sci Trop Med Hyg 1987; 81:222-9.

30. Luquetti AD, Miles MA, Rassi A, de Rezende JM, de Souza AA, Povoa MM, et al. Trypanosoma cruzi: zimodemes associated with acute and chronic Chagas’ disease in central Brazil. Trans Roy Sci Trop Med Hyg 1986; 80:462-70.

31. Carneiro M, Romanha AJ, Chiari E. Biological characterization of Trypanosoma cruzi strains from different zymodemes and schizodemes. Mem Inst Oswaldo Cruz 1991; 86:387-97.

32. Brener Z, Wendel S, Camargo ME, Rassi A. Chagas disease-American Tripanosomiasis: its impact on transfusion and clinical medical. Brazil 1992. Publ. Cientif. No. 126 (ISBN 917432J236).

33. Mendoza González J, Miranda Lluck E, Velazco Castrejón O, Tinoco Reyna O, Maciel Pérez M. Cardiopatía chagásica crónica. Presentación de 60 casos. Arch Inst Cardiol Mex 1995; 65:546-50.

34. Morel C, Chiari E, Flessman Camargo E, Mattei DM, Romanha AJ, Simpson L. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 1980; 77:6810-14.

35. Zavala-Castro JE, Velazco-Castrejón O, Hernández R. Molecular characterization of mexican stocks of Trypanosoma cruzi using total DNA. Am J Trop Med Hyg 1992; 47:201-9.

36. Dietrich P, Dussan MP, Floeter-Winter LM, Trebilcok MH, Plessman E, Soares MB. Restriction fragment length polymorphisms in the ribosomal gene spacers of Trypanosoma cruzi and Trypanosoma cororhini. Mol Biochem Parasitol 1990; 42:13-20.

37. Fernandes CD, Murta SM, Ceravolo IP, Krug LP, Vigidal PG, Steindel M, et al. Characterization of Trypanosoma cruzi strains isolated from chronic chagasic patients, triatomines and opossums naturally infected from the State of Rio Grande so Sul, Brazil. Mem Inst Oswaldo Cruz 1997; 92:343-51.

38. Stothard JR, Frame IA, Carrasco HJ, Miles MA. On the molecular taxonomy of Trypanosoma cruzi using riboprinting. Parasitology 1998 ; 117(Pt3) :243-7.